Diagnosis and Treatment of Patients With Cystic Fibrosis

Launched by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (NIDDK) · Nov 3, 1999

Keywords

ClinConnect Summary

This clinical trial is focused on understanding cystic fibrosis (CF), a genetic condition that can lead to issues with the lungs, liver, pancreas, and diabetes. The goal of the study is to collect samples and information from patients receiving standard care for CF. This information will help researchers learn more about how CF affects people and the different genetic factors involved.

Eligible participants include anyone aged 4 years and older who has been diagnosed with CF or is a family member of someone with the condition. Participants will be asked to provide samples and data, which will be used for future research. It’s important to note that individuals with certain other medical or psychiatric conditions may not be able to join the study, as these could affect the results. If you or a loved one are interested in this study, it could be a great opportunity to contribute to important research that may improve understanding and treatment of cystic fibrosis.

Gender

ALL

Eligibility criteria

• • INCLUSION CRITERIA
• • Patients with known or suspected CF and family members of patients with CF.
• • \>=4 years of age
• • EXCLUSION CRITERIA
• • -Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.